Last reviewed · How we verify

NCT04160273: ESPT-PP

Evaluation of Postpartum Posttraumatic Stress Disorder at Angers University Hospital (ESPT-PP)

Completed NA Last updated 25 July 2025
What this trial tests

NA trial testing patient questionnaire and telephone follow-up in Delivery in 1,451 participants. Completed in 12 March 2025.

Timeline
5 March 2021
Primary endpoint
5 March 2024
12 March 2025

Quick facts

Lead sponsorUniversity Hospital, Angers
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment1,451
Start date5 March 2021
Primary completion5 March 2024
Estimated completion12 March 2025
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Angers

Who can join

18 and older, female only, with Delivery or Post Partum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to estimate the prevalence of post-traumatic stress disorder (PTSD) at one month in women who have given birth at the University Hospital of Angers over a period of 1 year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Delivery

Currently open trials in the same condition.

Other University Hospital, Angers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04160273.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing